Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network survey

Cardio-Oncology - 2020
Diego Sadler1, Jeanne M. DeCara2, Joerg Herrmann3, Anita Arnold4, Ashoke Kumar Ghosh5, Husam Abdel‐Qadir6, Eric H. Yang7, Sebastian Szmit8, Nausheen Akhter9, Monika Leja10, Carolina Maria Pinto Domingues Carv Silva11, J. Raikhelkar12, Sherry-Ann Brown13, Susan Dent14, Rupal O’Quinn15, Franck Thuny16, Rohit Moudgil17, Luis E. Raez18, Tochukwu Okwuosa19, Andrés J. Daniele20, Brenton Bauer21, Lavanya Kondapalli22, Roohi Ismail‐Khan23, Jorge A. Lax24, Anne Blaes25, Zeina Nahleh1, Leah Elson1, Lauren A. Baldassarre26, Vlad G. Zaha27, Vijay Rao28, Daniel Sierra Lara29, Kerry Skurka28
1Heart and Vascular Center, Cleveland Clinic Florida, Weston, USA
2University of Chicago, Chicago, USA
3Mayo Clinic, Rochester, USA
4Lee Health, Ft. Myers, USA
5Barts Heart Centre, St. Bartholomew’s Hospital and University College London’s Hospital, London, UK
6Women’s College Hospital and Peter Munk Cardiac Centre, University of Toronto, Toronto, Canada
7UCLA Cardio-Oncology Program, University of California, Los Angeles, USA
8Centre of Postgraduate Medical Education, Warsaw, Poland
9Northwestern Feinerg School of Medicine, Chicago, USA
10University of Michigan, Ann Arbor, USA
11University of Sao Paulo, Sao Paulo, Brazil
12Columbia University Irving Medical Center, New York, USA
13Medical College of Wisconsin, Milwaukee, USA
14Duke University, Durham, USA
15University of Pennsylvania, Philadelphia, USA
16Aix-Marseille University, Marseille, France
17Cleveland Clinic, Cleveland, USA
18Memorial Health Care, Florida International University, Miami, USA
19Rush University Medical Center, Chicago, USA
20Roffo Institute, Buenos Aires, Argentina
21Torrance Memorial Medical Center, Torrance, USA
22University of Colorado, Aurora, USA
23H.Lee Moffitt Cancer Center, Tampa, USA.
24Hospital Cosme Argerich, Buenos Aires, Argentina
25University of Minnesota, Minneapolis, USA
26Yale School of Medicine, New Haven, USA
27UT Southwestern, Dallas, USA
28Franciscan Health, Indianapolis, USA
29Instituto Nacional de Cardiologia, Ciudad de Mexico, Mexico

Tóm tắt

AbstractBackgroundRe-allocation of resources during the COVID-19 pandemic has resulted in delays in care delivery to patients with cardiovascular disease and cancer. The ability of health care providers to provide optimal care in this setting has not been formally evaluated.ObjectivesTo assess the impact of COVID-19 resource re-allocation on scheduling, testing, elective procedures, telemedicine access, use of new COVID-19 therapies, and providers’ opinions on healthcare policies among oncology and cardiology practitioners.MethodsAn electronic survey was conducted by a cardio-oncology collaborative network through regional and state chapters of the American College of Cardiology, American Society of Clinical Oncology, and the International Cardio-Oncology Society. Descriptive statistics were reported by frequency and proportion for analyses, and stratified categorically by geographic region and specialty.ResultsOne thousand four hundred fifteen providers (43 countries) participated: 986 cardiologists, 306 oncologists, and 118 trainees/internal medicine. 63% (195/306) of oncologists vs 92% (896/976) of cardiologists reported cancellations of treatments/elective procedures (p = 0.01). 46% (442/970) of cardiologists and 25% (76/303) of oncologists modified the scope of their practice (p = < 0.001). Academic physicians (74.5%) felt better supplied with personal protective equipment (PPE) vs non-academic (74.5% vs 67.2%;p = 0.018). Telemedicine was less common in Europe 81% (74/91), and Latin America 64% (101/158), than the United States, 88% (950/1097) (p = < 0.001). 95% of all groups supported more active leadership from medical professional societies.ConclusionsThese results support initiatives to promote expanded coverage for telemedicine, increased access to PPE, better testing availability and involvement of medical professional societies to help with preparedness for future health care crisis.

Từ khóa


Tài liệu tham khảo

Johns Hopkins University Coronavirus Resource Center. Daily update.

WHO. World Health statistics. 2019. Monitoring health for the sustainable development goals.

Li B, Yang J, Zhao F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109:531–8. https://doi.org/10.1007/s00392-020-01626-9.

Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–7.

Xia Y, Jin R, Zhao J, Li W, Shen H. Risk of COVID-19 for patients with cancer. Lancet Oncol. 2020;21:e180.

Kuderer N, Choueiri T, Shah D, et al. Clinical impact of COVID-19 in patients with cancer (CCC19): a cohort study. Lancet. 2020;395(102410):1907–18 https://doi.org/10.1016/S0140-6736(20)31187-9.

Ivanova LTD, Stoykova Z, Kostadinova T. Viral Diseases in Transplant and Immunocompromised Patients. In: K M, editor. Immunopathology and Immunomodulation: InTechOpen, 2015. Book Chapter 7. Rijeka: In Tech. https://doi.org/10.5772/59217.

Tuech JJ, Gangloff A, Di Fiore F, et al. Strategy f or the practice of digestive and oncological surgery during the COVID 19 epidemic. Jvissurg. 2020;04:005.

COVID Surg Collaborative. Gobal guidance for surgical care during the COVID 19 pandemic, BJS; 2020. https://doi.org/10.1002/bjs11646.

Skulstad H, Cosyns B, Popescu B, et al. COVID-19 pandemic and cardiac imaging: EACVI recommendations in precautions, indications, prioritization, and protections for patients and healthcare personnel. Eur Heart J-CV Imag. 2020;21(6):592–8.

Driggin E, Madhavan N, Bikdeli V, et al. Cardiovascular considerations for patients, healthcare workers, and health systems during the COVID-19 pandemic. J Amer Coll Card. 2020;75(18):2352–71.

Word Health Organization: Rational use of personal protective equipment (PPE) for Coronavirus disease (COVID-19). Interim guidance 19 March 2020.

Infection prevention and control of epidemic-and pandemic-prone acute respiratory infections in health care. Geneva: World Health Organization; 2014 (Accessed 27 February 2020).

Ranney M, Griffeth V, Jha A. Critical supply shortages-The need for ventilators and personal protective equipment during the COVID 19 pandemic. N Engl J Med. 2020;3:82 e41.

Iacobucci G. COVID 19. Doctors still at considerable risk from lack of PPE, BMA warns. BMJ. 2020;368:m1316.

Livingston E, Desai A, Berkwits M. Sourcing personal protective equipment during the COVID-19 pandemic. JAMA. 2020;323(19):1912–4.

Cohen J, Kupferschmidt K. Countries test tactics in “war” against COVID-19. Science. 2020;367(6484):1287–8.

Fudulu DP, Angelini GD. The COVID-19 crisis: reflections on cardiothoracic surgery training. J Card Surg. 2020;35(8):1765–6.

Melvin SC, Wiggins C, Burse N, Thompson E, Monger M. The role of public Health in COVID-19 emergency response efforts from a rural Health perspective. Prev Chronic Dis. 2020;17:E70.

Schneider E. Failing the test-The tragic data gap undermining the US pandemic response. N Engl J Med. 2020. https://doi.org/10.1056/NEJMp2014836.

Dhama K, Sharun K, Tiwari R, et al. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapies and treatments. Hum Vaccines Immunotherapies. https://doi.org/10.1080/21645515.2020.1735227.

Sultana A, Sharma R, Hossain M, Bhattacharya S, Purohit N. Burnout Among Healthcare Providers During COVID-19 Pandemic: Challenges and Evidence-based Interventions. SocArXiv; 2020. https://doi.org/10.20529/IJME.2020.73.

Dewey C, Hingle S, Goelz E, et al. Supporting clinicians during the COVID-19 pandemic. Ann Int Med. 2020; https://doi.org/10.7326/M20-1033.

Wysocki PJ, Kwinta Ł, Potocki P, et al. Systemic treatment of patients with solid tumors during the COVID-19 (SARS-CoV-2) pandemic- recommendations of the polish Society of Clinical Oncology. Oncol Clin Pract. 2020;16(2):41–51. https://doi.org/10.5603/OCP.2020.0012.

Ebinger J, Shah PK. The. Declining admissions for acute cardiovascular illness: the COVID 19 paradox. J Amer Coll Cardiol. JACC. 2020;05(039).

Bhatt A, Moscone A, Mc Elrath E, et al. Declines in hospitalizations for acute cardiovascular conditions during the COVID 19 pandemic: a multicenter tertiary care experience. J Am Coll Cardiol. 2020. Epublished. https://doi.org/10.1016/j.jacc.2020.05.038.

Mahmud E, Dauerman H, et al. Mangement of acute myocardial infarction during the COVID 19 pandemic. J Am Coll Cardiol. 2020. Epublished. https://doi.org/10.1016/j.jacc.2020.04.039.

Ueda M, Martins R, et al. Managing cancer care during the COVID 19 pandemic. Agility and collaboration toward a common goal. JNCCN. 2020:1–4. https://doi.org/10.6004/jnccn.2020.7560.

Calabro L, Peters S, et al. Challenges in lung cancer therapy during the COVID 19 pandemic. Lancet Respir Med. 2020. https://doi.org/10.1016/S2213-2600(20)30170-3 [Epub ahead of print].

Maringe G, Spicer J, et al. The impact on Covid 19 pandemic on cancer deaths due to delay in diagnosis in England, UK. Lancet Oncol. 2020;21:1023–34.

Van de Haar J, Hoes LR, Coles CE, et al. Caring for patients with cancer in the COVID-19 era. Nat Med. 2020;26:665–71 https://doi.org/10.1038/s41591-020-0874-8.

Chikwee J, Gaudino M, Hameed I, et al. Committee recommendations for resuming cardiac surgery activity in the SARS-COV-2 era: guidance from an international cardiac surgery consortium. Ann Thorac Surg. 2020; https://doi.org/10.1016/j.athoracsur.2020.05.004.

Rao P, Diamond J, Korjian S, et al. The impact of the COVID-19 pandemic in cardiovascular fellows in training: a national survey. J Am Coll Cardiol. 2020. Unpublished. https://doi.org/10.1016/j.jacc.2020.06.027.

Fix OK, Serper M. Telemedicine and Telehepatology during the COVID 19 pandemic. Clin Liver Dis. 2020;15(5):187–90.

Smith A, Thomas E, Snoswell C, et al. Telehealth for global emergencies. Implications for COVID 19. Sage J. 2020. https://doi.org/10.1177/1357633X20916567.

Ohannessian R, Duong TA, Odone A. Global telemedicine implementation and integration within health systmes to fight the COVID 19 pandemic: a call to action. JMIR Public Health Surveill 2020;6(2):e18810.

Eberly L, Khatana S, Nathan A, et al. Telemedicine outpatient cardiovascular care during the COVID 19 pandemic: Bridging or opening the digital divide? Circulation. 2020; https://doi.org/10.1161/CIRCULATIONAHA.120.048185.

Grein J, Ohmagari N, Shin D, et al. Compassionate use of remdesivir for patients with COVID 19. NEJM. 2020. https://doi.org/10.1056/NEJMoa2007016.

Wang Y, Zhang D, Du H, et al. Remdesivir in adults with severe COVID 19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 395(10236):1569–78.

Beigel J, Tomashek KM, Dodd el et al, for the ACTT-1 Study Group Members. Remdesivir for the treatment of COVID 19. NEJM 2020. https://doi.org/10.1056/NEJMoa2007764.

Zhang C, Wu Z, Li J-W, et al. Cytokine release syndrome in COVID-19: interleukin 6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimic Agents. 2020;55(5) https://doi.org/10.1016/j.ijantimicag.2020.105954.

Alzghari S, Acuna V. Supportive treatment with tocilizumab for COVID-19: a systematic review. J Clin Virol. 2020;127:104380. https://doi.org/10.1016/j.jcv.2020.104380.

Goldman JD, Lyle D, Hui D, et al. Remdesivir for 5 or 10 days in patients with severe COVID 19. NEJM. 2020;27. https://doi.org/10.1056/NEJMoa2015301.

Dolin R, Hirsch M. Remdesivir, an important first step. N Engl J Med. 2020. https://doi.org/10.1056/NEJMe2018715.

Hopkins Tanne J, Hayasaki E, Zastrow M, et al. COVID 19. How doctors and healthcare systems are tackling coronavirus worldwide. BMJ. 2020;368:m1090.

Brzezinski A, Kecht V, Van Dijcke D, Wright A. Belief in Science Influences Physical Distancing in Response to COVID-19 Lockdown Policies (April 30, 2020). University of Chicago, Becker Friedman Institute for Economics Working Paper No. 2020-56. Available at SSRN: https://ssrn.com/abstract=3587990 or https://doi.org/10.2139/ssrn.3587990.

Khosrawipour V, Lau H, et al. Failure in initial stage containment of global COVID-19 epicenters. J Med Virol. 2020; https://doi.org/10.1002/jmv.25883.

Anelli F, Leoni G, Monaco R, et al. Italian doctors call for protecting healthcare workers and boosting community surveillance during covid-19 outbreak. BMJ. 2020;368:m1254. https://doi.org/10.1136/bmj.m1254.

Public Health, Medical Associations Call on Federal Authorities, State and Local Governments to Prioritize Safety in COVID-19 Policies. ACC, ASCO and 40 Professional medical societies joint statement. April 29 2020.

Mahmud E, Dauerman HL, Welt FGP, Messenger JC, Rao SV, Grines C, et al. Management of acute myocardial infarction during the COVID-19 pandemic: a consensus statement from the Society for Cardiovascular Angiography and Interventions (SCAI), the American College of Cardiology (ACC), and the American College of Emergency Physicians (ACEP). Catheter Cardiovasc Interv. 2020;96(2):336–45.

Marron JM, Joffe S, Jagsi R, Spence RA, Hlubocky FJ. Ethics and resource scarcity: ASCO recommendations for the oncology community during the COVID-19 pandemic. J Clin Oncol. 2020;38(19):2201–5.

Shah PB, Welt FGP, Mahmud E, Phillips A, Kleiman NS, Young MN, et al. Triage considerations for patients referred for structural heart disease intervention during the COVID-19 pandemic: an ACC/SCAI position statement. Cardiovasc Intervent. 2020;13(12):1484-8. https://doi.org/10.1016/j.jcin.2020.04.001. ISSN 1936-8798.

Thông tin
Thông tin xuất bản

Cardio-Oncology

Thông tin tác giả